(BPT) - Michelle Trites, her husband and their 3-year-old daughter all have Type 1 diabetes. Diabetes is an ever-present part of their lives and ensuring that they have tools in their tool kits to handle low blood sugar emergencies is a top priority.
Ever since Michelle was diagnosed at 13 years old, the Glucagon Emergency Kit has been a constant presence — at school, at work, and on her person at all times. But not anymore. After learning about ready-to-use glucagon, Michelle made sure that everyone in her family replaced the old red kit with Gvoke HypoPen®, a ready-to-use rescue pen for treatment of very low blood sugar in adults and kids ages 2 and older.
Michelle believes the emergency glucagon kit is cumbersome to use due to its 12-step administration process. “That was a lot to ask from non-medical professionals who could get squeamish just looking at a needle, much less completing so many steps in a high-stakes emergency,” Michelle said. In a usability study, only 31% of users could use the glucagon injection kit correctly.
Eli Lilly and Company, a producer of the GEK kit, recently announced that it is discontinuing distribution of the kit on December 31, 2022. The decision was reportedly made due to innovations in the glucagon market and highlights the importance of providing patients with products that enable simpler administration during critical moments of need.
As a result of this news, all patients that currently have a prescription for Eli Lilly’s GEK will need to be transitioned to another option.
The Trites recommend that people with diabetes and their caregivers ask their physician for Gvoke HypoPen®. “Everyone should have Gvoke HypoPen in their tool kit,” said Michelle. “It can help you confidently manage a low blood sugar emergency.”
Gvoke HypoPen®, the simple solution you can count on:
Talk to your doctor about adding Gvoke HypoPen® to your diabetes toolkit and visit GvokeGlucagon.com to learn more.
“We are focused on making our treatments simple for patients or caregivers to administer,” said Ken Johnson, senior vice president for Global Development and Medical Affairs at Xeris Pharmaceuticals. “Xeris is committed to offering historically hard-to-administer and potentially life-saving medications in innovative ready-to-use injectables.”
INDICATION AND SAFETY SUMMARY
GVOKE is a prescription medicine used to treat very low blood sugar (severe hypoglycemia) in adults and kids with diabetes ages 2 years and above. It is not known if GVOKE is safe and effective in children under 2 years of age.
Do not use GVOKE if:
GVOKE MAY CAUSE SERIOUS SIDE EFFECTS, INCLUDING:
High blood pressure. GVOKE can cause high blood pressure in certain people with tumors in their adrenal glands.
Low blood sugar. GVOKE can cause low blood sugar in certain people with tumors in their pancreas called insulinomas by making too much insulin in their bodies.
Serious allergic reaction. Call your doctor or get medical help right away if you have a serious allergic reaction including:
COMMON SIDE EFFECTS
The most common side effects of GVOKE in adults include:
The most common side effects of GVOKE in children include:
These are not all the possible side effects of GVOKE. For more information, ask your doctor.
Call your doctor for medical advice about side effects. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Before using GVOKE, tell your doctor about all your medical conditions, including if you:
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
HOW TO USE
HOW TO STORE
Keep GVOKE and all medicines out of the reach of children.
For more information, call 1-877-937-4737 or go to https://gvokeglucagon.com/
Please see the Full Prescribing Information for Gvoke: https://gvokeglucagon.com/pdf/gvoke-prescribing-information.pdf